WUXI, China, Jan. 12, 2026 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO),…
Read More
SHANGHAI and SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ — Oricell Therapeutics Holdings Limited (“Oricell” or “the Company”), a global leader…
Read More